For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...
Johnson is now back on the transplant list to receive a deceased donor’s kidney. “They only last, this is a lengthy ...
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...
Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...
8d
News Medical on MSNStudy shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetesKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
More than 90,000 people are on the waiting list for a kidney in the U.S. Unfortunately, less than a third of those waiting ...
New Hampshire native Tim Andrews was quite happy to spend his 67th birthday on Wednesday at Mass General Hospital (MGH). On ...
NEW YORK, March 5, 2025 /PRNewswire/ -- Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived ...
Dell Seton Medical Center opened a new, expanded clinic for its Adult Abdominal Transplant Center, which aims to provide ...
Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with ...
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results